Some Useful Sources

We have provided here an annotated list of resources, key organisations and programmes that support young fathers and details of data sources for secondary use. The information complements the citations within the individual articles in this themed section

Inhibition of Cholinergic Signaling Causes Apoptosis in Human Bronchioalveolar Carcinoma

Recent case-controlled clinical studies show that bronchioalveolar carcinomas (BAC) are correlated with smoking. Nicotine, the addictive component of cigarettes, accelerates cell proliferation through nicotinic acetylcholine receptors (nAChR). In this study, we show that human BACs produce acetylcholine (ACh) and contain several cholinergic factors including acetylcholinesterase (AChE), choline acetyltransferase (ChAT), choline transporter 1 (CHT1, SLC5A7), vesicular acetylcholine transporter (VAChT, SLC18A3), and nACh receptors (AChRs, CHRNAs). Nicotine increased the production of ACh in human BACs, and ACh acts as a growth factor for these cells. Nicotine-induced ACh production was mediated by α7-, α3β2-, and β3-nAChRs, ChAT and VAChT pathways. We observed that nicotine upregulated ChAT and VAChT. Therefore, we conjectured that VAChT antagonists, such as vesamicol, may suppress the growth of human BACs. Vesamicol induced potent apoptosis of human BACs in cell culture and nude mice models. Vesamicol did not have any effect on EGF or insulin-like growth factor-II–induced growth of human BACs. siRNA-mediated attenuation of VAChT reversed the apoptotic activity of vesamicol. We also observed that vesamicol inhibited Akt phosphorylation during cell death and that overexpression of constitutively active Akt reversed the apoptotic activity of vesamicol. Taken together, our results suggested that disruption of nicotine-induced cholinergic signaling by agents such as vesamicol may have applications in BAC therapy

Supernova 2017eaw: Molecule and Dust Formation from Infrared Observations

We present infrared (IR) photometry and spectroscopy of the Type II-P SN 2017eaw and its progenitor in the nearby galaxy NGC 6946. Progenitor observations in the Ks band in four epochs from 1 yr to 1 day before the explosion reveal no significant variability in the progenitor star greater than 6% that lasts longer than 200 days. SN 2017eaw is a typical SN II-P with near-IR and mid-IR photometric evolution similar to those of SNe 2002hh and 2004et, other normal SNe II-P in the same galaxy. Spectroscopic monitoring during the plateau phase reveals a possible high-velocity He I 1.083 μm absorption line, indicative of a shock interaction with the circumstellar medium. Spectra between 389 and 480 days postexplosion reveal a strong CO first overtone emission at 389 days, with a line profile matching that of SN 1987A from the same epoch, indicating ~10^(−3) M⊙ of CO at 1800 K. From the 389 days epoch until the most recent observation at 566 days, the first overtone feature fades while the 4.5 μm excess, likely from the CO fundamental band, remains. This behavior indicates that the CO has not been destroyed, but that the gas has cooled enough that the levels responsible for first overtone emissions are no longer populated. Finally, the evolution of Spitzer 3.6 μm photometry shows evidence for dust formation in SN 2017eaw, with a dust mass of 10^(−6) or 10^(−4) M⊙ assuming carbonaceous or silicate grains, respectively

The Dust Properties of Two Hot R Coronae Borealis Stars and a Wolf-Rayet Central Star of a Planetary Nebula: in Search of a Possible Link

We present new Spitzer/IRS spectra of two hot R Coronae Borealis (RCB) stars, one in the Galaxy,V348 Sgr, and one lying in the LMC, HV 2671. These two objects may constitute a link between the RCB stars and the late Wolf-Rayet ([WCL]) class of central stars of planetary nebula (CSPNe) such as CPD -56 8032 that has little or no hydrogen in their atmospheres. HV 2671 and V348 Sgr are members of a rare subclass that has significantly higher effective temperatures than most RCB stars, but sharing the traits of hydrogen deficiency and dust formation that define the cooler RCB stars. The [WC] CSPNe star, CPD -56 8032, displays evidence for dual-dust chemistry showing both PAHs and crystalline silicates in its mid-IR spectrum. HV 2671 shows strong PAH emission but shows no sign of having crystalline silicates. The spectrum of V348 Sgr is very different from those of CPD -56 8032 and HV 2671. The PAH emission seen strongly in the other two stars is not present. Instead, the spectrum is dominated by a broad emission centered at about 8.2 micron. The mid-IR spectrum of CPD -56 8032 shows emission features that may be associated with C60. The other two stars do not show evidence for C60. HV 2671 has also been detected by Herschel/PACS and SPIRE. V348 Sgr and CPD -56 8032 have been detected by AKARI/FIS. These data were combined with Spitzer, IRAS, 2MASS and other photometry to produce their spectral energy distributions from the visible to the far-IR. Monte Carlo radiative transfer modeling was used to study the circumstellar dust around these stars. HV 2671 and CPD -56 8032 require both a flared inner disk with warm dust and an extended diffuse envelope with cold dust to to fit their SEDs. The SED of V348 Sgr can be fit with a much smaller disk and envelope.Comment: 20 pages, 5 figures, accepted for publication in The Astronomical Journa

IC 4663: the first unambiguous [WN] Wolf-Rayet central star of a planetary nebula

We report on the serendipitous discovery of the first central star of a planetary nebula (PN) that mimics the helium- and nitrogen-rich WN sequence of massive Wolf–Rayet (WR) stars. The central star of IC 4663 (PN G346.2−08.2) is dominated by broad He II and N V emission lines which correspond to a [WN3] spectral type. Unlike previous [WN] candidates, the surrounding nebula is unambiguously a PN. At an assumed distance of 3.5 kpc, corresponding to a stellar luminosity of 4000 L⊙, the V= 16.9 mag central star remains 4–6 mag fainter than the average luminosity of massive WN3 stars even out to an improbable d= 8 kpc. The nebula is typical of PNe with an elliptical morphology, a newly discovered asymptotic giant branch (AGB) halo, a relatively low expansion velocity (vexp= 30 km s−1) and a highly ionized spectrum with an approximately solar chemical abundance pattern. The [WN3] star is hot enough to show Ne VII emission (T*= 140 ± 20 kK) and exhibits a fast wind (v∞= 1900 km s−1), which at d= 3.5 kpc would yield a clumped mass-loss rate of forumla= 1.8 × 10−8 M⊙ yr−1 with a small stellar radius (R*= 0.11 R⊙). Its atmosphere consists of helium (95 per cent), hydrogen (<2 per cent), nitrogen (0.8 per cent), neon (0.2 per cent) and oxygen (0.05 per cent) by mass. Such an unusual helium-dominated composition cannot be produced by any extant scenario used to explain the H-deficiency of post-AGB stars. The O(He) central stars share a similar composition and the discovery of IC 4663 provides the first evidence for a second He-rich/H-deficient post-AGB evolutionary sequence [WN] →O(He). This suggests that there is an alternative mechanism responsible for producing the majority of H-deficient post-AGB stars that may possibly be expanded to include other He-rich/H-deficient stars such as R Coronae Borealis stars and AM Canum Venaticorum stars. The origin of the unusual composition of [WN] and O(He) central stars remains unexplained

Benefits and risks of the hormetic effects of dietary isothiocyanates on cancer prevention

The isothiocyanate (ITC) sulforaphane (SFN) was shown at low levels (1-5 µM) to promote cell proliferation to 120-143% of the controls in a number of human cell lines, whilst at high levels (10-40 µM) it inhibited such cell proliferation. Similar dose responses were observed for cell migration, i.e. SFN at 2.5 µM increased cell migration in bladder cancer T24 cells to 128% whilst high levels inhibited cell migration. This hormetic action was also found in an angiogenesis assay where SFN at 2.5 µM promoted endothelial tube formation (118% of the control), whereas at 10-20 µM it caused significant inhibition. The precise mechanism by which SFN influences promotion of cell growth and migration is not known, but probably involves activation of autophagy since an autophagy inhibitor, 3-methyladenine, abolished the effect of SFN on cell migration. Moreover, low doses of SFN offered a protective effect against free-radical mediated cell death, an effect that was enhanced by co-treatment with selenium. These results suggest that SFN may either prevent or promote tumour cell growth depending on the dose and the nature of the target cells. In normal cells, the promotion of cell growth may be of benefit, but in transformed or cancer cells it may be an undesirable risk factor. In summary, ITCs have a biphasic effect on cell growth and migration. The benefits and risks of ITCs are not only determined by the doses, but are affected by interactions with Se and the measured endpoint

Copy number, linkage disequilibrium and disease association in the FCGR locus.

The response of a leukocyte to immune complexes (ICs) is modulated by receptors for the Fc region of IgG (FcgammaRs), and alterations in their affinity or function have been associated with risk of autoimmune diseases, including systemic lupus erythematosus (SLE). The low-affinity FcgammaR genomic locus is complex, containing regions of copy number variation (CNV) which can alter receptor expression and leukocyte responses to IgG. Combined paralogue ratio tests (PRTs) were used to distinguish three intervals within the FCGR locus which undergo CNV, and to determine FCGR gene copy number (CN). There were significant differences in FCGR3B and FCGR3A CNV profiles between Caucasian, East Asian and Kenyan populations. A previously noted association of low FCGR3B CN with SLE in Caucasians was supported [OR = 1.57 (1.08-2.27), P = 0.018], and replicated in Chinese [OR = 1.65 (1.25-2.18), P = 4 x 10(-4)]. There was no association of FCGR3B CNV with vasculitis, nor with malarial or bacterial infection. Linkage disequilibrium (LD) between multi-allelic FCGR3B CNV and SLE-associated SNPs in the FCGR locus was defined for the first time. Despite LD between FCGR3B CNV and a variant in FcgammaRIIB (I232T) which abolishes inhibitory function, both reduced CN of FCGR3B and homozygosity of the FcgammaRIIB-232T allele were individually strongly associated with SLE risk. Thus CN of FCGR3B, which controls IC responses and uptake by neutrophils, and variations in FCGR2B, which controls factors such as antibody production and macrophage activation, are important in SLE pathogenesis. Further interpretations of contributions to pathogenesis by FcgammaRs must be made in the context of LD involving CNV regions

JWST Discovery of Dust Reservoirs in Nearby Type IIP Supernovae 2004et and 2017eaw

Supernova (SN) explosions have been sought for decades as a possible source of dust in the Universe, providing the seeds of galaxies, stars, and planetary systems. SN 1987A offers one of the most promising examples of significant SN dust formation, but until the James Webb Space Telescope (JWST), instruments have traditionally lacked the sensitivity at both late times (>1 yr post-explosion) and longer wavelengths (i.e., >10 um) to detect analogous dust reservoirs. Here we present JWST/MIRI observations of two historic Type IIP SNe, 2004et and SN 2017eaw, at nearly 18 and 5 yr post-explosion, respectively. We fit the spectral energy distributions as functions of dust mass and temperature, from which we are able to constrain the dust geometry, origin, and heating mechanism. We place a 90% confidence lower limit on the dust masses for SNe 2004et and 2017eaw of >0.014 and >4e-4 M_sun, respectively. More dust may exist at even colder temperatures or may be obscured by high optical depths. We conclude dust formation in the ejecta to be the most plausible and consistent scenario. The observed dust is radiatively heated to ~100-150 K by ongoing shock interaction with the circumstellar medium. Regardless of the best fit or heating mechanism adopted, the inferred dust mass for SN 2004et is the second highest (next to SN 1987A) inferred dust mass in extragalactic SNe thus far, promoting the prospect of SNe as potential significant sources of dust in the Universe.Comment: 12 pages, 7 figures, submitting to MNRA

Supernova 2017eaw: Molecule and Dust Formation from Infrared Observations

We present infrared (IR) photometry and spectroscopy of the Type II-P SN 2017eaw and its progenitor in the nearby galaxy NGC 6946. Progenitor observations in the Ks band in four epochs from 1 yr to 1 day before the explosion reveal no significant variability in the progenitor star greater than 6% that lasts longer than 200 days. SN 2017eaw is a typical SN II-P with near-IR and mid-IR photometric evolution similar to those of SNe 2002hh and 2004et, other normal SNe II-P in the same galaxy. Spectroscopic monitoring during the plateau phase reveals a possible high-velocity He I 1.083 μm absorption line, indicative of a shock interaction with the circumstellar medium. Spectra between 389 and 480 days postexplosion reveal a strong CO first overtone emission at 389 days, with a line profile matching that of SN 1987A from the same epoch, indicating ~10^(−3) M⊙ of CO at 1800 K. From the 389 days epoch until the most recent observation at 566 days, the first overtone feature fades while the 4.5 μm excess, likely from the CO fundamental band, remains. This behavior indicates that the CO has not been destroyed, but that the gas has cooled enough that the levels responsible for first overtone emissions are no longer populated. Finally, the evolution of Spitzer 3.6 μm photometry shows evidence for dust formation in SN 2017eaw, with a dust mass of 10^(−6) or 10^(−4) M⊙ assuming carbonaceous or silicate grains, respectively

Factors Affecting Intention to Receive and Self-Reported Receipt of 2009 Pandemic (H1N1) Vaccine in Hong Kong: A Longitudinal Study

Background: Vaccination was a core component for mitigating the 2009 influenza pandemic (pH1N1). However, a vaccination program's efficacy largely depends on population compliance. We examined general population decision-making for pH1N1 vaccination using a modified Theory of Planned Behaviour (TBP). Methodology: We conducted a longitudinal study, collecting data before and after the introduction of pH1N1 vaccine in Hong Kong. Structural equation modeling (SEM) tested if a modified TPB had explanatory utility for vaccine uptake among adults. Principal Findings: Among 896 subjects who completed both the baseline and the follow-up surveys, 7% (67/896) reported being "likely/very likely/certain" to be vaccinated (intent) but two months later only 0.8% (7/896) reported having received pH1N1 vaccination. Perception of low risk from pH1N1 (60%) and concerns regarding adverse effects of the vaccine (37%) were primary justifications for avoiding pH1N1 vaccination. Greater perceived vaccine benefits (β = 0.15), less concerns regarding vaccine side-effects (β = -0.20), greater adherence to social norms of vaccination (β = 0.39), anticipated higher regret if not vaccinated (β = 0.47), perceived higher self-efficacy for vaccination (β = 0.12) and history of seasonal influenza vaccination (β = 0.12) were associated with higher intention to receive the pH1N1 vaccine, which in turn predicted self-reported vaccination uptake (β = 0.30). Social norm (β = 0.70), anticipated regret (β = 0.19) and vaccination intention (β = 0.31) were positively associated with, and accounted for 70% of variance in vaccination planning, which, in turn subsequently predicted self-reported vaccination uptake (β = 0.36) accounting for 36% of variance in reported vaccination behaviour. Conclusions/Significance: Perceived low risk from pH1N1 and perceived high risk from pH1N1 vaccine inhibited pH1N1 vaccine uptake. Both the TPB and the additional components contributed to intended vaccination uptake but social norms and anticipated regret predominantly associated with vaccination intention and planning. Vaccination planning is a more significant proximal determinant of uptake of pH1N1 vaccine than is intention. Intention alone is an unreliable predictor of future vaccine uptake. © 2011 Liao et al.published_or_final_versio